IntroductionDirector’

s Welcom

e

INFLUENZA

Department of DefenseSeasonal Influenza Vaccination Program Leaders Briefing

2011-12

UNCLASSIFIED

2

Outline

1. Influenza Disease2. DoD Influenza Policies3. DoD Vaccines4. Vaccination Screening5. Documentation

PURPOSE: to inform command leadership about the details of the DoD Seasonal Influenza Vaccination Program.

3

Influenza Season 2011-12

“Annual influenza vaccination is the most effective method for preventing influenza virus infection and its complications”

“Influenza viruses can cause disease among persons in any age group, but rates of infection are highest among children. Rates of serious illness and death are highest among persons aged >65 years, children aged <2 years, and persons of any age who have medical conditions that place them at increased risk for complications from influenza.

An annual average of approximately 36,000 deaths during 1990–1999 and 226,000 hospitalizations during 1979–2001 have been associated with influenza epidemics.”

ACIP Recommendations for Prevention and Control of Seasonal Influenza with Vaccines MMWR, August 2010

4

Influenza Virus

• Respiratory disease caused by influenza type A or B viruses• Transmitted person to person by airborne droplets• Direct or indirect contact with secretions• Symptoms

Abrupt onset of fever (101-102°F) Muscle pain Sore throat Nonproductive cough Headache

• WHO selects prevalent strains for vaccine 2- Influenza A, 1- Influenza B virus

• Advisory Committee on Immunization Practices Recommends annual vaccination to all persons 6 months and older

Department of Defense (DoD) Guidance for the use of Influenza Vaccine for the 2011-2012

Influenza Season (2 Aug 11)Air Force

Air Force 2011-2012 Influenza Immunization Program Guidance (25 Jul 11)

Army 2011-2012 Influenza Vaccine Immunization Program• Operations Order 11-50 (17 Jul 11)

Coast Guard 2011-2012 Seasonal Influenza (Flu) Immunization Program

ALCOAST (01 Aug 11)Navy / Marines

2011-2012 Navy Influenza Vaccination and Reporting Policy• BUMED (13 Jul 11)

Tricare Management Activity 32 CFR Part 199 (13 Jul 11)

DoD Influenza Policies

5

6

Vaccine Manufacturers

DoD contracted with three manufacturers

• Inactivated, Injectable vaccine Sanofi-Pasteur - Fluzone CSL Biotherapies – Afluria

• Live, Intranasal Vaccine MedImmune – Flumist

• 2011-2012 Trivalent Influenza Vaccine A/California/7/2009 (H1N1) A/Perth/16/2009 (H3N2) B/Brisbane/60/2008

7

Prioritization

No vaccine shortage is anticipated this year

Continue until vaccine supply is exhausted or expired

Should an unexpected vaccine shortage occur, DoD will follow ACIP guidelines and continue to reserve first available vaccine for deployed, deploying, mission essential and medical high risk personnel.

In accordance with (IAW) HA Policy 08-005, “Policy for Mandatory Seasonal Influenza Immunization for Civilian Health Care Personnel Who Provide Direct Patient Care in Department of Defense Military Treatment Facilities”, military treatment facilities are directed to require all civilian health care personnel (HCP) who provide direct patient care in DoD MTFs be immunized against seasonal influenza infection each year as a condition of employment, unless there is a documented medical or religious reason not to be immunized.

8

Screening

Health Status evaluated for Individual allergies (eggs, thimerosal, vaccine components, latex) Individual medical conditions (pregnancy, history of Guillain-Barre’ Syndrome, asthma, immune-compromised)

Appropriate exemptions protect the service member

9

Adverse Event after Vaccination

Most common adverse reactions with influenza vaccinations

Injectable: Soreness, tenderness, pain and swelling at the injection site. Tiredness, headache and muscle aches

Intranasal: Runny nose or nasal congestion in all ages and sore throat in adults

Vaccine Adverse Event Reporting System (VAERS)www.vaers.hhs.gov

Contact VAERS 1-800-822-7967

Vaccine Healthcare Centers (VHC) Network1-866-210-6469 (24 hrs)

www.vhcinfo.org

10

Immunization Tracking and Reporting

Service members should receive influenza vaccination by 1 December 2011

• Services will monitor influenza immunization compliance through their respective Immunization Tracking Systems

• On 1 December 2011 compliance will be categorized as Green (≥ 90% immunized) Amber (80-90% immunized) Red (<80% immunized)

• Proper documentation• Date, location, vaccine brand, lot number and signature• MILVAX will report influenza vaccination compliance rate to the Surgeons

General as requested

11

Exemption Documentation

Regional Analyst POC Map

• Medical Exemption Codes Medical Temporary (MT) - Recent live virus vaccine,

referred for medical consultation, antiviral treatment Medical Permanent (MP) - Medical contraindication

by physician

• Administrative Exemption Codes Administrative emergency leave (AL) - up to 30 days Administrative PCS (AP) - up to 90 days Administrative separation (AS) - 60 or 180 days

12

Contact Us

For more information about DoD Influenza Vaccination Program,

or if you have any vaccine related questions please contact

the MILVAX Agency.

vaccines@amedd.army.mil

(877) GET-VACC

(877) 438-8222

www.vaccines.mil/flu

13

www.vaccines.mil

www.vaccines.mil